Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROKIDNEY CORP. | 135,000 | reported | 28 May 2026 | tx 5+401,548 |
| BridgeBio Pharma, Inc. | 10,832 | reported | 15 Dec 2020 | tx 14+156,935−937 |
| Eidos Therapeutics, Inc. | 0 | reported | 26 Jan 2021 | tx 33+63,294−416,525 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | PROKIDNEY CORP. | 135,000 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | PROKIDNEY CORP. | 125,862 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | PROKIDNEY CORP. | 62,558 | 0.00 USD | deriv |
| 29 Jun 2023 | GRANT_AWARD | PROKIDNEY CORP. | 48,128 | 0.00 USD | deriv |
| 11 Jul 2022 | GRANT_AWARD | PROKIDNEY CORP. | 30,000 | 0.00 USD | |
| 27 Oct 2020 | GIFT | Eidos Therapeutics, Inc. | 3,000 | 0.00 USD | |
| 26 Jan 2021 | TENDER | Eidos Therapeutics, Inc. | 303,525 | — | |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 60,000 | — | deriv |
| 13 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 300 | 126.39 USD | |
| 13 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 2,000 | 125.35 USD | |
| 13 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 1,498 | 123.48 USD | |
| 13 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 572 | 122.27 USD | |
| 13 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 696 | 121.11 USD | |
| 13 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 4,934 | 124.72 USD | |
| 15 Dec 2020 | GRANT_AWARD | BridgeBio Pharma, Inc. | 10,832 | 0.00 USD | deriv |
| 15 Dec 2020 | GRANT_AWARD | BridgeBio Pharma, Inc. | 5,717 | 0.00 USD | deriv |
| 15 Dec 2020 | GRANT_AWARD | BridgeBio Pharma, Inc. | 8,912 | 0.00 USD | deriv |
| 02 Dec 2020 | SALE | Eidos Therapeutics, Inc. | 3,798 | 89.63 USD | |
| 02 Dec 2020 | SALE | Eidos Therapeutics, Inc. | 200 | 92.97 USD | |
| 02 Dec 2020 | SALE | Eidos Therapeutics, Inc. | 300 | 91.89 USD | |
| 02 Dec 2020 | SALE | Eidos Therapeutics, Inc. | 702 | 90.63 USD | |
| 16 Nov 2020 | EXERCISE | BridgeBio Pharma, Inc. | 469 | — | |
| 16 Nov 2020 | EXERCISE | BridgeBio Pharma, Inc. | 469 | 0.00 USD | deriv |
| 29 Oct 2020 | SALE | Eidos Therapeutics, Inc. | 1,300 | 71.90 USD | |
| 29 Oct 2020 | SALE | Eidos Therapeutics, Inc. | 3,700 | 72.60 USD |